We’re excited to share major industry news that marks a significant milestone for Scinomix. Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and life science and industrial solutions, has completed the acquisition of Scinomix, Inc., strengthening both companies’ position in the life sciences market.

A Shared Commitment to Innovation and Customer Success

Scinomix found a natural fit within Ingersoll Rand's life sciences division. Both companies share a deep commitment to employee-centric cultures, excellent customer experience, and continuous innovation. We believe in empowering team members through owner mindsets and curiosity. We are dedicated to creating high-quality, innovative solutions that help customers work more efficiently. Together, we can advance growth strategies and expand our global impact. 

End-to-End Laboratory Automation Solutions

Scinomix will continue to provide the laboratory automation solutions our customers rely on today, including tube labeling and handling, tube laser etching, liquid handling, and plate labeling systems used across clinical, pharmaceutical, biotechnology, forensic, and agricultural labs. The addition of Ingersoll Rand’s global scale, complementary technologies, and resources to our automation expertise enhances our ability to provide comprehensive, end-to-end automation solutions. We are positioned to accelerate product development, broaden our solution offerings, and bring greater efficiency and precision to more lab environments worldwide. Expanded capabilities and shared expertise allow us to better help customers improve traceability, accuracy, and throughput while continuing to provide the high level of service and collaboration they expect from Scinomix. 

As part of Ingersoll Rand's life sciences division, we are excited about the opportunities ahead for our customers, partners, and employees. We look forward to growing together, advancing innovation, and continuing to support the vital work happening in labs every day.